The decision to have a child usually requires a feeling of stability and confidence in the future, says Natascha Braumann, Director of Global Government and Public Affairs for Fertility at EMD Serono, on this week’s episode of Friday Podcasts.  But with COVID-19, especially in the first months of the pandemic, there was no feeling of stability. “No one knew what was going to happen.”

“I believe that we’re experiencing a national reckoning and in this unique moment, I definitely see an opportunity for Congress, but also for our local governments to enact policies that begin to address our country’s greatest ills,” said Representative Alma Adams (D-NC-12) at a recent Wilson Center event on women, race, and COVID-19 in the United States. “COVID-19 has revealed what the Black community and communities of color have known for a long time—health outcomes are further compounded by systemic and structural racism. COVID-19 has exposed what women have known for a long time—gender inequality exists, it threatens economic empowerment, and it increases vulnerabilities.” 

“NCDs have raised the risk of and the severity of the COVID-19 infection,” says Dr. Belén Garijo, Executive Board Member and CEO of Healthcare at Merck KGaA Darmstadt, Germany, in this week’s Friday Podcast. Women living with NCDs like cardiovascular disease, hypertension, cancer, mental health disorders, multiple sclerosis, and diabetes, have an increased risk of severe complications and death from COVID-19. “When you take a look at the mortality rate for one million inhabitants, you see a lot of diversity, and what has been consistent amongst all the countries is the association between severity of the infection and underlying diseases,” says Garijo.

Around the world, approximately 18 million women of reproductive age die each year because of non-communicable diseases (NCDs), and two in every three deaths among women are due to an NCD. In fact, NCDs have been the leading cause of death among women globally for at least the past 30 years. And yet, women’s specific needs are often excluded from conversations about NCDs. They are underrepresented in clinical research and the effect of NCDs on women in particular is rarely considered. NCD-related symptoms during pregnancy are commonly misinterpreted or dismissed by clinicians.